Motherwort Injection for Preventing Postpartum Hemorrhage in Women with Vaginal Delivery: A Systematic Review and Meta-Analysis of Randomized Evidence

Table 1

Characteristics of included studies.

Study	Intervention	No. of participants	Age (year)	Gestation (weeks)	Usage	Dosage	Risk factor
			Mean (SD)	Mean (SD)
Chen GY, 2008	M	100	NR	NR	Consecutive	140mg	No
	O	100	NR	NR		70U
Chen XQ, 2012	M	100	28.9(3.9)	38.7(1.3)	Consecutive	140mg	No
	O	100	29.1(4)	38.6(1.2)		70U
Li W, 2014	M	40	27.2(1.2)	39.1(1.3)	Consecutive	120mg	Yes
	O	40	26.3(0.9)	37.5(0.8)		30U
Liu WL, 2011	M	40	NR	NR	Consecutive	60mg	No
	O	39	NR	NR		30U
Lin JH, 2009	M	150	NR	NR	Consecutive	100mg	No
	O	149	NR	NR		40U
Lu LQ, 2011	M	300	NR	NR	Immediate	40mg	No
	O	300	NR	NR		20U
Ren J, 2009	M	33	27.6(2.9)	39.3(1.2)	Consecutive	100mg	No
	O	34	28.9(3.2)	39.1(1.1)		40U
Sun YW, 2012	M	100	28.6(2.9)	39.1(1.1)	Consecutive	200mg	NR
	O	100	28.3(2.5)	39.2(1.0)		20U
Cheng L, 2013	M+O	400	NR	NR	Immediate	20U+40mg	No
	O	400	NR	NR		20U
Dai YX, 2015	M+O	90	29.0(2.9)	39.2(1.2)	Immediate	20U+40mg	Yes
	O	90	29.0(3.0)	38.6(1.5)		20U
Huang LR, 2011	M+O	50	26.0(1.1)	37.6(1.1)	Immediate	20U+20mg	No
	O	50	NR	NR		20U
Li N, 2009	M+O	90	NR	NR	Immediate	20U+20mg	No
	O	90	NR	NR		20U
Liu F, 2018	M+O	42	23.5(4.1)	NR	Immediate	30U+120mg	NR
	O	42	24.6(4.2)	NR		30U
Liu LE, 2016	M+O	223	NR	NR	Immediate	20U+40mg	No
	O	224	NR	NR		20U
Liu JM, 2017	M+O	67	29.4(4.2)	39(1.9)	Immediate	30U+120mg	NR
	O	67	30(4.1)	39.7(2.0)		30U
Liu YN, 2018	M+O	49	25.2(2.1)	NR	Consecutive	30U+120mg	NR
	O	47	24.4(1.9)	NR		30U
Lv LZ, 2011	M+O	100	27.0(2.5)	38.2(2.4)	Immediate	10U+20mg	Yes
	O	100	26.0(3.1)	38.7(2.1)		10U
Ma DY, 2016	M+O	70	28.0(6.5)	NR	Consecutive	20U+80mg	Yes
	O	70	26.0(5.7)	NR		20U
Shi H, 2015	M+O	50	NR	NR	Consecutive	70U+140mg	No
	O	50	NR	NR		70U
Si RGL, 2016	M+O	190	22-37	NR	Immediate	10U+20mg	No
	O	190		NR		10U
Sun X, 2018	M+O	45	26.7(2.2)	39.2(1.2)	Immediate	30U+120mg	NR
	O	45	26.6(2.4)	39.2(1.3)		30U
Sun YW, 2015	M+O	127	25.0(2.8)	40.1(0.1)	Immediate	20U+40mg	No
	O	127	26.0(2.8)	40.2(0.1)		20U
Wang L, 2008	M+O	200	NR	NR	Immediate	20U+40mg	NR
	O	200	NR	NR		20U
Wang YH, 2015	M+O	50	26.0(3.6)	39.2(1.2)	Consecutive	20U+80mg	NR
	O	50	26.0(3.2)	38.9(1.1)		20U
Wang YX, 2014	M+O	150	NR	NR	Immediate	20U+40mg	NR
	O	150	NR	NR		20U
Wei YB, 2016	M+O	56	22-38	38-42	Immediate	20U+20mg	No
	O	56				20U
Wu JJ, 2018	M+O	25	NR	NR	Consecutive	70U+140mg	Yes
	O	25	NR	NR		70U
Wu N, 2016	M+O	45	26.0(3.5)	39.7(1.5)	Consecutive	20U+80mg	NR
	O	45	27.0(3.3)	39.4(1.3)		20U
Xue QJ, 2018	M+O	152	28.6(2.3)	39.5(1.3)	Consecutive	60U+120mg	No
	O	152	28.5(2.2)	39.2(1.2)		80U
Yang XF, 2018	M+O	100	26.5(1.7)	39.2(1.3)	Immediate	20U+40mg	No
	O	100	26.7(1.5)	39.1(1.4)		20U
Yuan WJ, 2015	M+O	200			Consecutive	20U+80mg	No
	O	200				20U/40U
Yue H, 2011	M+O	50	NR	NR	Consecutive	70U+140mg	Yes
	O	50	NR	NR		70U
Zhang HH, 2014	M+O	100	26.0(1.2)	38.3(1.3)	Consecutive	70U+140mg	Yes
	O	100	26.0(1.2)	39.2(1.0)		70U
Zhao XY, 2011	M+O	50	27.0(1.5)	39.0(1.3)	Immediate	20U+20mg	NR
	O	50	27.0(1.7)	39.2(1.4)		20U
Zheng XH, 2012	M+O	60	28.0(1.6)	39.1(1.2)	Immediate	10U+20mg	NR
	O	60	28.0(1.7)	39.2(1.2)		10U
Zhu WC, 2009	M+O	108	27.0(2.5)	38.7(2.1)	Immediate	20U+40mg	NR
	O	108	26.0(3.1)	38.2(2.4)		20U
Wang P, 2012	M	95	20-34	37-44	Consecutive	100mg	No
	O	95				40U
	M+O	95				40U+100mg